Menu Close

Now Is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries

Peyton Thompson, Jonathan B Parr, Alix Boisson, Devin Razavi-Shearer, Oliver C Ezechi, Su H Wang, Joseph D Tucker


Summary

Fewer than half of the world’s infants have access to the birth dose of hepatitis B vaccine (HBV), which prevents mother-to-child transmission of HBV and subsequent liver cancer. Now is the time to expand access for infants born in low-resource settings.

en_USEnglish